Dolly A. Parasrampuria

Subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma (COLUMBA): a multicentre, open-label, non-inferiority, randomised, phase 3 trial

María‐Victoria Mateos, Hareth Nahi, Wojciech Legieć et al. · The Lancet Haematology · 2020 · 241 citations · Full text

Medicine, Oncology, Pharmacology +14

PET Study Examining Pharmacokinetics, Detection and Likeability, and Dopamine Transporter Receptor Occupancy of Short- and Long-Acting Oral Methylphenidate

Thomas Spencer, Joseph Biederman, Patrick E. Ciccone et al. · American Journal of Psychiatry · 2006 · 202 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Pharmacokinetics, safety, and tolerability of edoxaban in end-stage renal disease subjects undergoing haemodialysis

Thomas Marbury, Nobuko Matsushima, Shuquan Chen et al. · Thrombosis and Haemostasis · 2015 · 132 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Edoxaban drug–drug interactions with ketoconazole, erythromycin, and cyclosporine

Dolly A. Parasrampuria, Jeanne Mendell, Minggao Shi et al. · British Journal of Clinical Pharmacology · 2016 · 97 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Why Drugs Fail in Late Stages of Development: Case Study Analyses from the Last Decade and Recommendations

Dolly A. Parasrampuria, Leslie Z. Benet, Amarnath Sharma · The AAPS Journal · 2018 · 79 citations

Medicine, Pharmacology, Drug Repurposing +9